Company / Inventory
IGC Pharma, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$1.4M
FY2025
5-year range
$1.4M / $5.5M
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has declined for 4 consecutive years, from $5M in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -20.4%.
Declined from $3M to $1M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -27.4%
- 5-Year CAGR
- -20.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s inventory has declined for 4 consecutive years.
- 5-year CAGR of -20.4%, indicating a declining trend.
- In FY2025, inventory decreased 11.7% year-over-year.
- Peak inventory was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | -11.7% |
| FY2024 | $1.5M | -41.9% |
| FY2023 | $2.7M | -25.3% |
| FY2022 | $3.5M | -35.2% |
| FY2021 | $5.5M | +29.0% |
| FY2020 | $4.2M | +1611.7% |
| FY2019 | $248.0K | -49.0% |
| FY2018 | $486.5K | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $162.1K | -77.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026